Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Bruxelles  >  UCB    UCB   BE0003739530

UCB (UCB)
Mes dernières consult.
Most popular
  Report  
Real-time Quote. Real-time Tradegate - 07/20 12:43:12 pm
70.69 EUR   +0.64%
07/17UCB : Transparency notification
AQ
07/17UCB : and Amgen Resubmit Biologics Licence Application for EVENITYTM..
AQ
07/13ICER panel votes against elagolix for endometriosis
AQ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 201520162017201820192020
Sales3 8764 1784 5304 5204 6794 800
EBITDA8211 0311 3751 3261 3951 484
Operating profit (EBIT)5777961 1301 1031 1791 252
Pre-Tax Profit (EBT)4267649881 0231 1481 216
Net income623520753757852936
P/E ratio25,622,116,517,415,614,1
EPS ( € )3,252,764,004,044,504,99
Dividend per Share ( € )1,101,151,181,241,301,34
Yield1,32%1,89%1,78%1,77%1,85%1,91%
Reference price ( € )83.2360.9166.1870.2470.2470.24
Announcement Date02/26/2016
06:02am
02/23/2017
06:45am
02/22/2018
06:29am
---
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 201520162017201820192020
Debt921838525---
Finance---64,45461 167
Operating income (EBITDA)8211 0311 3751 3261 3951 484
Leverage
(Debt/EBITDA)
1,12x0,81x0,38x---
Capital Expenditure146138100152135147
Book Value Per Share (BVPS)29,2 €29,6 €30,9 €33,4 €35,8 €38,8 €
Cash Flow per Share1,28 €3,86 €-5,33 €5,72 €5,90 €
Announcement Date02/26/2016
06:02am
02/23/2017
06:45am
02/22/2018
06:29am
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 13 783 M€ -
Entreprise Value (EV) 13 718 M€ 13 237 M€
Valuation 2018e 2019e
P/E ratio (Price / EPS) 17,4x 15,6x
Capitalization / Revenue 3,05x 2,95x
EV / Revenue 3,03x 2,83x
EV / EBITDA 10,3x 9,49x
Yield (DPS / Price) 1,77% 1,85%
Price to book (Price / BVPS) 2,10x 1,96x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 24,4% 25,2%
operating Leverage (Delta EBIT / Delta Sales) -11,4x 1,97x
Net Margin (Net Profit / Revenue) 16,7% 18,2%
ROA (Net Profit / Asset) 8,59% 8,78%
ROE (Net Profit / Equities) 13,8% 14,1%
Rate of Dividend 30,7% 29,0%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   3,37% 2,88%
Cash Flow / Sales 22,2% 23,0%
Capital Intensity (Assets / Sales) 1,95x 2,07x
Financial Leverage (Net Debt / EBITDA) -0,05x -0,39x
EPS & Dividend